1
Postma, Maarten J.
Veröffentlicht in: Postma , M J 2010 , ' Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands : Recent publication reinforces favorable cost-effectiveness despite misleading conclusion ' , Vaccine , vol. 28 , no. 4 , pp. 873-874 . https://doi.org/10.1016/j.vaccine.2009.10.109;
2010
Veröffentlicht in: Postma , M J 2010 , ' Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands : Recent publication reinforces favorable cost-effectiveness despite misleading conclusion ' , Vaccine , vol. 28 , no. 4 , pp. 873-874 . https://doi.org/10.1016/j.vaccine.2009.10.109;
2010
2
3
Boersma, Cornelis, Broere, Adriaan, Postma, Maarten J.
Veröffentlicht in: Value in Health ; volume 13, issue 6, page 853-856 ; ISSN 1098-3015;
2010
Veröffentlicht in: Value in Health ; volume 13, issue 6, page 853-856 ; ISSN 1098-3015;
2010
4
Postma, Maarten J., Beutels, Philippe, Jager, Johannes C.
Veröffentlicht in: Postma , M J , Beutels , P & Jager , J C 2003 , ' Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections : Cost-effectiveness analyses and implications for the Netherlands ' , Expert review of vaccines , vol. 2 , no. 4 , pp. 477-482 . https://doi.org/10.1586/14760584.2.4.477;
2003
Veröffentlicht in: Postma , M J , Beutels , P & Jager , J C 2003 , ' Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections : Cost-effectiveness analyses and implications for the Netherlands ' , Expert review of vaccines , vol. 2 , no. 4 , pp. 477-482 . https://doi.org/10.1586/14760584.2.4.477;
2003
5
van der Pol, Simon, Postma, Maarten J., Boersma, Cornelis
Veröffentlicht in: The European Journal of Health Economics ; ISSN 1618-7598 1618-7601;
2024
Veröffentlicht in: The European Journal of Health Economics ; ISSN 1618-7598 1618-7601;
2024
6
7
Rozenbaum, Mark H., De Cao, Elisabetta, Postma, Maarten J.
Veröffentlicht in: Rozenbaum , M H , De Cao , E & Postma , M J 2012 , ' Cost-effectiveness of pertussis booster vaccination in the Netherlands ' , Vaccine , vol. 30 , no. 50 , pp. 7327-7331 . https://doi.org/10.1016/j.vaccine.2012.06.026;
2012
Veröffentlicht in: Rozenbaum , M H , De Cao , E & Postma , M J 2012 , ' Cost-effectiveness of pertussis booster vaccination in the Netherlands ' , Vaccine , vol. 30 , no. 50 , pp. 7327-7331 . https://doi.org/10.1016/j.vaccine.2012.06.026;
2012
8
Zeevat, Florian, Wilschut, Jan C., Boersma, Cornelis, Postma, Maarten J.
Veröffentlicht in: Zeevat , F , Wilschut , J C , Boersma , C & Postma , M J 2023 , ' Reducing Hospital Capacity Needs for Seasonal Respiratory Infections : The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults ' , Value in Health , vol. 26 , no. 4 , pp. 461-464 . https://doi.org/10.1016/j.jval.2022.11.020;
2023
Veröffentlicht in: Zeevat , F , Wilschut , J C , Boersma , C & Postma , M J 2023 , ' Reducing Hospital Capacity Needs for Seasonal Respiratory Infections : The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults ' , Value in Health , vol. 26 , no. 4 , pp. 461-464 . https://doi.org/10.1016/j.jval.2022.11.020;
2023
9
10
van der Pol, Simon, Degener, Fabian, Postma, Maarten J., Vemer, Pepijn
Veröffentlicht in: van der Pol , S , Degener , F , Postma , M J & Vemer , P 2017 , ' An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands ' , Value in Health , vol. 20 , no. 3 , pp. 388-396 . https://doi.org/10.1016/j.jval.2016.10.015;
2017
Veröffentlicht in: van der Pol , S , Degener , F , Postma , M J & Vemer , P 2017 , ' An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands ' , Value in Health , vol. 20 , no. 3 , pp. 388-396 . https://doi.org/10.1016/j.jval.2016.10.015;
2017